Good Fellow Healthcare Holdings Toekomstige groei

Future criteriumcontroles 0/6

Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Good Fellow Healthcare Holdings te voorspellen.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Healthcare winstgroei	18.6%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Recent updates

We're Hopeful That Good Fellow Healthcare Holdings (HKG:8143) Will Use Its Cash Wisely

Dec 30

Here's Why We're Watching Good Fellow Healthcare Holdings' (HKG:8143) Cash Burn Situation

Aug 10

Good Fellow Healthcare Holdings (HKG:8143) Will Have To Spend Its Cash Wisely

Nov 10

Is Good Fellow Healthcare Holdings (HKG:8143) A Risky Investment?

Jul 06

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Good Fellow Healthcare Holdings onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

SEHK:8143 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (HKD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
9/30/2024	23	-2	-16	-1	N/A
6/30/2024	30	-9	N/A	N/A	N/A
3/31/2024	39	-17	-15	-1	N/A
12/31/2023	47	-8	N/A	N/A	N/A
9/30/2023	53	-6	-2	0	N/A
6/30/2023	55	-6	N/A	N/A	N/A
3/31/2023	55	-6	-4	-1	N/A
12/31/2022	55	-25	N/A	N/A	N/A
9/30/2022	56	-27	-14	-12	N/A
6/30/2022	55	-8	N/A	N/A	N/A
3/31/2022	54	-13	-25	-23	N/A
12/31/2021	57	-12	N/A	N/A	N/A
9/30/2021	58	-14	-52	-29	N/A
6/30/2021	57	-34	N/A	N/A	N/A
3/31/2021	54	-30	-21	1	N/A
12/31/2020	45	-59	N/A	N/A	N/A
9/30/2020	66	-58	-9	79	N/A
6/30/2020	100	-47	N/A	N/A	N/A
3/31/2020	145	-50	-52	35	N/A
12/31/2019	199	-35	N/A	N/A	N/A
9/30/2019	256	-29	-11	4	N/A
6/30/2019	293	-54	N/A	N/A	N/A
3/31/2019	327	-50	6	21	N/A
12/31/2018	350	-123	N/A	N/A	N/A
9/30/2018	343	-124	1	22	N/A
6/30/2018	338	-108	N/A	N/A	N/A
3/31/2018	330	-103	N/A	25	N/A
12/31/2017	315	-33	N/A	N/A	N/A
9/30/2017	308	-21	N/A	41	N/A
6/30/2017	290	-25	N/A	N/A	N/A
3/31/2017	270	-30	N/A	-98	N/A
12/31/2016	-718	-8	N/A	N/A	N/A
9/30/2016	-424	-26	N/A	68	N/A
6/30/2016	-66	-27	N/A	N/A	N/A
3/31/2016	253	-30	N/A	185	N/A
12/31/2015	1,549	-28	N/A	N/A	N/A
9/30/2015	1,652	-22	N/A	-73	N/A
6/30/2015	1,722	-18	N/A	N/A	N/A
3/31/2015	1,780	-506	N/A	0	N/A
12/31/2014	1,966	-501	N/A	N/A	N/A
9/30/2014	2,027	-495	N/A	3	N/A
6/30/2014	2,079	-486	N/A	N/A	N/A
3/31/2014	2,243	22	N/A	22	N/A
12/31/2013	2,212	37	N/A	N/A	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van 8143 boven de spaarquote ( 2.3% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van 8143 naar verwachting sneller zal groeien dan de markt Hong Kong

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van 8143 naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van 8143 naar verwachting sneller zal groeien dan de markt Hong Kong.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van 8143 naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van 8143 naar verwachting over 3 jaar hoog zal zijn

Good Fellow Healthcare Holdings Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Good Fellow Healthcare Holdings Limited Provides Earnings Guidance for the Nine Months Ended 31 December 2022

Good Fellow Healthcare Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 September 2022

Recent updates

Good Fellow Healthcare Holdings Limited to Report First Half, 2025 Results on Nov 08, 2024

Good Fellow Healthcare Holdings Limited, Annual General Meeting, Aug 16, 2024

Full year 2024 earnings released: HK$0.03 loss per share (vs HK$0.01 loss in FY 2023)

New minor risk - Financial data availability

Good Fellow Healthcare Holdings Limited to Report Fiscal Year 2024 Results on Jun 28, 2024

New major risk - Market cap size

Good Fellow Healthcare Holdings Limited Appoints Mr. Lin Yaomin as Independent Non-Executive Director and A Member of Each of the Audit Committee, the Remuneration Committee and the Nomination and Corporate Governance Committee

Good Fellow Healthcare Holdings Limited Announces Resignation of Dr. Lam Huen Sum as Independent Non-Executive Director, Member Each of the Remuneration Committee, the Audit Committee and the Nomination and Corporate Governance Committee

Second quarter 2024 earnings released: HK$0.006 loss per share (vs HK$0.005 loss in 2Q 2023)

Good Fellow Healthcare Holdings Limited to Report First Half, 2024 Results on Nov 08, 2023

New major risk - Market cap size

Good Fellow Healthcare Holdings Limited Announces Executive Changes

First quarter 2024 earnings released

New major risk - Share price stability

Full year 2023 earnings released: HK$0.002 loss per share (vs HK$0.004 loss in FY 2022)

Good Fellow Healthcare Holdings Limited to Report Fiscal Year 2023 Results on Jun 16, 2023

Third quarter 2023 earnings released: HK$0.001 loss per share (vs HK$0.002 loss in 3Q 2022)

Good Fellow Healthcare Holdings Limited Provides Earnings Guidance for the Nine Months Ended 31 December 2022

Good Fellow Healthcare Holdings Limited to Report Q3, 2023 Results on Feb 08, 2023

We're Hopeful That Good Fellow Healthcare Holdings (HKG:8143) Will Use Its Cash Wisely

Insufficient new directors

Second quarter 2023 earnings released

Good Fellow Healthcare Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 September 2022

Insufficient new directors

First quarter 2023 earnings released

Here's Why We're Watching Good Fellow Healthcare Holdings' (HKG:8143) Cash Burn Situation

Good Fellow Healthcare Holdings Limited to Report Q1, 2023 Results on Aug 12, 2022

Good Fellow Healthcare Holdings Limited, Annual General Meeting, Aug 05, 2022

Full year 2022 earnings released: HK$0.004 loss per share (vs HK$0.01 loss in FY 2021)

Good Fellow Healthcare Holdings Limited to Report Fiscal Year 2022 Final Results on Jun 17, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Non-Executive Director Chenli Liu has left the company

Good Fellow Healthcare Holdings (HKG:8143) Will Have To Spend Its Cash Wisely

Second quarter 2022 earnings released: EPS HK$0.006 (vs HK$0.001 loss in 2Q 2021)

First quarter 2022 earnings released

Is Good Fellow Healthcare Holdings (HKG:8143) A Risky Investment?

Full year 2021 earnings released: HK$0.011 loss per share (vs HK$0.017 loss in FY 2020)

CEO & Executive Director Jiang Tao has left the company

Third quarter 2021 earnings released: HK$0.002 loss per share (vs HK$0.002 loss in 3Q 2020)

Good Fellow Healthcare Holdings Limited to Report Q3, 2021 Results on Feb 05, 2021

Good Fellow Healthcare Holdings Limited to Report First Half, 2021 Results on Nov 10, 2020

Earnings released

Good Fellow Healthcare Holdings Limited to Report Q1, 2021 Results on Aug 13, 2020

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven